Published in Surg Neurol on February 08, 2008
Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function. Proc Natl Acad Sci U S A (2011) 1.13
Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res (2010) 0.91
Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol (2010) 0.82
Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med (2015) 0.79
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model. Neuro Oncol (2013) 0.78
Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice. PLoS One (2014) 0.77
Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. Neurotherapeutics (2017) 0.75
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. Neuro Oncol (2016) 0.75
Impact of fellowship training on research productivity in academic neurological surgery. World Neurosurg (2013) 3.36
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg (2005) 2.19
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15
Coincident pituitary adenoma and sellar meningioma. Acta Neurochir (Wien) (2014) 2.01
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature. Spine (Phila Pa 1976) (2003) 1.86
Pituitary carcinoma: a review of the literature. Neurosurg Focus (2004) 1.77
Ruptured intracranial dermoid cysts: clinical, radiographic, and surgical features. Neurosurgery (2008) 1.69
Primary Intraosseous Skull Base Cavernous Hemangioma: Case Report. Skull Base (2003) 1.63
Metastases to the pituitary gland. Neurosurg Focus (2004) 1.63
Use of the h index in neurosurgery. Clinical article. J Neurosurg (2009) 1.60
Career satisfaction and burnout among U.S. neurosurgeons: a feasibility and pilot study. World Neurosurg (2012) 1.58
Transcortical-transforaminal microscopic approach for purely intraventricular craniopharyngioma. Neurosurg Focus (2013) 1.58
De novo fenestration of the optic nerve. Case illustration. J Neurosurg (2005) 1.58
Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg (2004) 1.55
Traumatic pseudoaneurysms of the head and neck: early endovascular intervention. J Vasc Surg (2007) 1.52
The combined transmastoid retro- and infralabyrinthine transjugular transcondylar transtubercular high cervical approach for resection of glomus jugulare tumors. Neurosurgery (2006) 1.52
Transnasal excerebration surgery in ancient Egypt. J Neurosurg (2012) 1.48
Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol (2006) 1.46
The frontotemporal (pterional) approach: an historical perspective. Neurosurgery (2012) 1.41
The management of trauma venous injury: civilian and wartime experiences. Perspect Vasc Surg Endovasc Ther (2006) 1.40
Tunneled lumbar drain. Technical note. J Neurosurg (2002) 1.39
Patton: death of a soldier. Historical vignette. J Neurosurg (2008) 1.39
Upper extremity arterial combat injury management. Perspect Vasc Surg Endovasc Ther (2006) 1.39
Venous trauma: new lessons and old debates. Perspect Vasc Surg Endovasc Ther (2011) 1.38
Aneurysms of the petrous internal carotid artery: anatomy, origins, and treatment. Neurosurg Focus (2004) 1.36
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res (2007) 1.31
Contemporary management of wartime vascular trauma. J Vasc Surg (2005) 1.29
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus (2010) 1.27
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery (2006) 1.22
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol (2010) 1.21
Neurosurgical workforce trends in the United States. J Neurosurg (2005) 1.18
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Call to action to prevent venous thromboembolism. J Vasc Surg (2009) 1.17
Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus (2004) 1.16
Fenestration of the oculomotor nerve by a duplicated posterior cerebral artery and aneurysm. Case report. J Neurosurg (2009) 1.15
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer (2007) 1.13
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg (2009) 1.12
Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol (2006) 1.09
Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol (2006) 1.08
Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2012) 1.07
Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg (2007) 1.06
Inflammatory pseudotumor of the cavernous sinus and skull base. Neurosurg Rev (2006) 1.05
Photophobia in a blind patient: An alternate visual pathway. Case report. J Neurosurg (2006) 1.05
Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery (2005) 1.04
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev (2007) 1.04
Hemorrhagic and nonhemorrhagic Rathke cleft cysts mimicking pituitary apoplexy. J Neurosurg (2008) 1.04
WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol (2008) 1.03
Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol (2006) 1.03
Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg (2003) 1.03
Surgical treatment of craniofacial fibrous dysplasia in adults. Neurosurg Rev (2013) 1.02
Molecular genetics of meningiomas. Neurosurg Focus (2005) 1.00
Subependymomas: an analysis of clinical and imaging features. Neurosurgery (2006) 1.00
The meaning of the prognostic factors in ruptured middle cerebral artery aneurysm with intracerebral hemorrhage. J Korean Neurosurg Soc (2012) 1.00
Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg (2004) 1.00
Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus (2004) 0.98
Porous polyethylene implant for cranioplasty and skull base reconstruction. Neurosurg Focus (2004) 0.98
Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum. J Vasc Surg (2014) 0.98
Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J Neurosurg (2003) 0.97
Embolic atrial myxoma causing aortic and carotid occlusion. Surg Neurol (2008) 0.97
Surgical approaches for resection of vestibular schwannomas: translabyrinthine, retrosigmoid, and middle fossa approaches. Neurosurg Focus (2012) 0.97
Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery. J Neurosurg (2005) 0.97
Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol (2005) 0.96
Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg (2004) 0.95
Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg (2007) 0.95
Surgical decision-making strategies in tuberculum sellae meningioma resection. Neurosurg Focus (2011) 0.94
Aberrant right subclavian artery syndrome: a case of chronic cough. J Vasc Surg (2003) 0.94
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer (2007) 0.94
Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care (2005) 0.93
What imaging studies are necessary for abdominal aortic endograft sizing? A prospective blinded study using conventional computed tomography, aortography, and three-dimensional computed tomography. J Vasc Surg (2005) 0.93
The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results of a case control study. J Trauma (2008) 0.93
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer (2007) 0.93
Development of contrast enhancement after long-term observation of a dysembryoplastic neuroepithelial tumor. J Neurooncol (2006) 0.93
Incidental meningiomas. Neurosurg Focus (2011) 0.92
Glioblastoma multiforme of the pineal region. J Neurooncol (2006) 0.92
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med (2012) 0.92
Intraventricular tanycytic ependymoma: case report and review of the literature. J Neurooncol (2005) 0.92
Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int (2013) 0.92
Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature. J Neurosurg (2004) 0.92
Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. J Neurosurg (2006) 0.92
Rathke cleft cyst intracystic nodule: a characteristic magnetic resonance imaging finding. J Neurosurg (2005) 0.92
In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed (2011) 0.92
Spontaneous hemorrhage associated with a pilomyxoid astrocytoma. Case report. J Neurosurg (2003) 0.92
Dynamic CT perfusion imaging for the detection of crossed cerebellar diaschisis in acute ischemic stroke. Korean J Radiol (2011) 0.91
ELTD1, a potential new biomarker for gliomas. Neurosurgery (2013) 0.91
Aberrant signaling pathways in meningiomas. J Neurooncol (2010) 0.91
Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg (2002) 0.91
Intracranial subarachnoid hemorrhage resulting from cervical spine dural arteriovenous fistulas: literature review and case presentation. Neurosurg Focus (2009) 0.91
Modified infratemporal fossa approach via lateral transantral maxillotomy: a microsurgical model. Surg Neurol (2002) 0.90